Great Reminder Post that reminds the board why all the LONGS are so EXCITED by Brilacidin!!!
Well done Farrell!!
In contrast Brilacidin may have 3 antiviral mechanisms of action. In addition it is a proven broad spectrum antibiotic and it has anti-inflammatory properties.
Brilacidin starts killing Covid 19 in the serum shortly after infusion. It does not require conversion to an active form like Remdesivir and Pfizers PF 07321332..Brilacidin is the only antiviral being studied which is viruidal. It attaches to the viral coat and destroys the virus shortly after contact.
The Pfizer drug is a prodrug, like Remdesivir, and has to be activated to its effective form.
In addition testing at the RBL demonstrated that Brilacidin prevents viral attachment to the cells.Computer simulations showed it may deactivate the virus's main protease.
Brilacidin has a number of anti-inflammatory properties which may limit the Covid 19 inflammatory cascade which leads to many complications including pulmonary failure.
It broad spectrum antibiotic may reduce the secondary infection rate in hospitalized patients which has been reported as high as 8%.
Brilacidin has been successful in all of its previous studies. The Phase 2 study is soon to be fully enrolled.
News 
Market Data 
Discover 
